Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;79:887-897

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kijima, K.
Right arrow Articles by Inada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kijima, K.
Right arrow Articles by Inada, M.
(Circulation Research. 1996;79:887-897.)
© 1996 American Heart Association, Inc.


Articles

Mechanical Stretch Induces Enhanced Expression of Angiotensin II Receptor Subtypes in Neonatal Rat Cardiac Myocytes

Kazuhisa Kijima, Hiroaki Matsubara, Satoshi Murasawa, Katsuya Maruyama, Yasukiyo Mori, Naohiko Ohkubo, Issei Komuro, Yoshio Yazaki, Toshiji Iwasaka, Mitsuo Inada

the Department of Medicine II (K.K., H.M., S.M., K.M., Y.M., N.O., T.I., M.I.), Kansai Medical University, Osaka, Japan, and the Department of Medicine III (I.K., Y.Y.), Tokyo University School of Medicine, Tokyo, Japan.

Correspondence to Hiroaki Matsubara, MD, Department of Medicine II, Kansai Medical University, Fumizonocho 10-15, Moriguchi, Osaka 570, Japan.

Mechanical stress plays a pivotal role in the development of cardiac hypertrophy during hemodynamic overload, and angiotensin (Ang) II secreted from stretched myocytes plays an important role in mechanical stretch–induced hypertrophy. In the present study, we examined stretch-induced expression of Ang II receptors in an in vitro stretch model using 1-day-old rat myocytes. Both Ang II type 1 receptor (AT1-R) and type 2 receptor (AT2-R) mRNA levels were upregulated by myocyte stretching with similar time courses: significant increases were evident 6 hours after stretching, maximal levels (2.8- and 3.3-fold, respectively) were observed at 12 hours, and these were sustained for up to 18 hours. Ang II receptor expression in fibroblast-rich cultures was not affected by stretching. Conditioned medium in which myocytes were stretched for 12 hours significantly downregulated AT1-R and AT2-R mRNA levels in recipient myocytes, and this effect was almost completely blocked by AT1-R antagonists but not AT2-R antagonists. Stretch-induced expression of AT1-R and AT2-R mRNAs was further increased by 27% and 31%, respectively, after pretreatment with AT1-R antagonists, suggesting that Ang II secreted from stretched myocytes downregulates both AT1-R and AT2-R. Western blot and binding assays showed that the number of AT1-Rs and AT2-Rs increased by 2.4- and 2.6-fold, respectively, without affecting receptor affinities. Inositol phosphate response to 0.5 µmol/L Ang II was enhanced 2.1-fold in stretched myocytes. Nuclear runoff assays and treatment with actinomycin D revealed that stretch-induced upregulation of AT1-R was mainly due to increased transcription, whereas that of AT2-R resulted from a stabilizing effect on AT2-R mRNA metabolism. Stretch-induced changes in levels of Ang II receptors were inhibited by genistein but not by H-7, staurosporin, and protein kinase C depletion or by BAPTA-AM. Exposure to cycloheximide did not affect stretch-induced changes. These findings indicate that nonsecretory pathways activated by myocyte stretching upregulate the expression of Ang II receptor subtypes transcriptionally and posttranscriptionally through mechanisms involving stretch-activated tyrosine kinases independently of de novo protein synthesis and that the AT1-R–mediated action of Ang II is functionally enhanced in stretched cardiac myocytes.


Key Words: angiotensin II • receptor • myocyte stretch • cardiac hypertrophy • cardiomyocyte




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Doi, T. Sakoda, T. Akagami, T. Naka, Y. Mori, T. Tsujino, T. Masuyama, and M. Ohyanagi
Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1279 - H1287.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Hanke, B. B. Holmes, Y. Xu, K. Nithipatikom, and W. B. Campbell
Endothelium-Derived Steroidogenic Factor Enhances Angiotensin II-Stimulated Aldosterone Release by Bovine Zona Glomerulosa Cells
Endocrinology, January 1, 2007; 148(1): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. L. Reudelhuber
The Continuing Saga of the AT2 Receptor: A Case of the Good, the Bad, and the Innocuous
Hypertension, December 1, 2005; 46(6): 1261 - 1262.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Fraccarollo, P. Galuppo, I. Schmidt, G. Ertl, and J. Bauersachs
Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction
Cardiovasc Res, July 1, 2005; 67(1): 97 - 105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. E. Spurrell, T. V. Murphy, and M. A. Hill
Intraluminal pressure stimulates MAPK phosphorylation in arterioles: temporal dissociation from myogenic contractile response
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1764 - H1773.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, K. Arakawa, and K. Saku
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2197 - 2204.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. J. Lips, L. J. deWindt, D. J.W. van Kraaij, and P. A. Doevendans
Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy
Eur. Heart J., May 2, 2003; 24(10): 883 - 896.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Gupta, N. H. Purcell, A. Lin, and S. Sen
Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy
J. Cell Biol., December 23, 2002; 159(6): 1019 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Baetz, R. S. Haworth, M. Avkiran, and D. Feuvray
The ERK pathway regulates Na+-HCO3- cotransport activity in adult rat cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2102 - H2109.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Matsubara
Renin-Angiotensin System in Human Failing Hearts : Message From Nonmyocyte Cells to Myocytes
Circ. Res., May 11, 2001; 88(9): 861 - 863.
[Full Text] [PDF]


Home page
Circ. Res.Home page
L. H. Opie and M. N. Sack
Enhanced Angiotensin II Activity in Heart Failure : Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes
Circ. Res., April 13, 2001; 88(7): 654 - 658.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Fujiyama, H. Matsubara, Y. Nozawa, K. Maruyama, Y. Mori, Y. Tsutsumi, H. Masaki, Y. Uchiyama, Y. Koyama, A. Nose, et al.
Angiotensin AT1 and AT2 Receptors Differentially Regulate Angiopoietin-2 and Vascular Endothelial Growth Factor Expression and Angiogenesis by Modulating Heparin Binding-Epidermal Growth Factor (EGF)-Mediated EGF Receptor Transactivation
Circ. Res., January 19, 2001; 88(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. E El-Sabban, K. A Hassan, A. E Birbari, K. M Bitar, and A. B Bikhazi
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 369 - 378.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
S. Busche, S. Gallinat, R.-M. Bohle, A. Reinecke, J. Seebeck, F. Franke, L. Fink, M. Zhu, C. Sumners, and T. Unger
Expression of Angiotensin AT1 and AT2 Receptors in Adult Rat Cardiomyocytes after Myocardial Infarction : A Single-Cell Reverse Transcriptase-Polymerase Chain Reaction Study
Am. J. Pathol., August 1, 2000; 157(2): 605 - 611.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Yi Xu, V. Menon, and B. I Jugdutt
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. G Stanley, H. Patel, A. L Knight, and B. Williams
Mechanical strain-induced human vascular matrix synthesis: The role of angiotensin II
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 32 - 35.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners
The angiotensin II type 2 receptor: an enigma with multiple variations
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Ozono, T. Matsumoto, T. Shingu, T. Oshima, Y. Teranishi, M. Kambe, H. Matsuura, G. Kajiyama, Z.-Q. Wang, A. F. Moore, et al.
Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R781 - R789.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. D. Dispersyn, M. Borgers, and W. Flameng
Apoptosis in chronic hibernating myocardium: sleeping to death?
Cardiovasc Res, February 1, 2000; 45(3): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt, Yi Xu, M. Balghith, R. Moudgil, and V. Menon
Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKC{varepsilon} Proteins and cGMP
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 301 - 311.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
Circ. Res., November 12, 1999; 85(10): 919 - 930.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Q. Liu
Focal Expression of Angiotensin II Type 1 Receptor and Smooth Muscle Cell Proliferation in the Neointima of Experimental Vein Grafts : Relation to Eddy Blood Flow
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2630 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. C Wollert and H. Drexler
The renin-angiotensin system and experimental heart failure
Cardiovasc Res, September 1, 1999; 43(4): 838 - 849.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Malhotra, J. Sadoshima, F. C. Brosius III, and S. Izumo
Mechanical Stretch and Angiotensin II Differentially Upregulate the Renin-Angiotensin System in Cardiac Myocytes In Vitro
Circ. Res., July 23, 1999; 85(2): 137 - 146.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Moriguchi, H. Matsubara, Y. Mori, S. Murasawa, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Shibasaki, Y. Tanaka, T. Nakajima, et al.
Angiotensin II–Induced Transactivation of Epidermal Growth Factor Receptor Regulates Fibronectin and Transforming Growth Factor-ß Synthesis via Transcriptional and Posttranscriptional Mechanisms
Circ. Res., May 14, 1999; 84(9): 1073 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. GRUDEN, S. THOMAS, D. BURT, W. ZHOU, G. CHUSNEY, L. GNUDI, and G. VIBERTI
Interaction of Angiotensin II and Mechanical Stretch on Vascular Endothelial Growth Factor Production by Human Mesangial Cells
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 730 - 737.
[Abstract] [Full Text]


Home page
HypertensionHome page
V. Robert, C. Heymes, J.-S. Silvestre, A. Sabri, B. Swynghedauw, and C. Delcayre
Angiotensin AT1 Receptor Subtype as a Cardiac Target of Aldosterone : Role in Aldosterone-Salt–Induced Fibrosis
Hypertension, April 1, 1999; 33(4): 981 - 986.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Harada, I. Komuro, T. Sugaya, K. Murakami, and Y. Yazaki
Vascular Injury Causes Neointimal Formation in Angiotensin II Type 1a Receptor Knockout Mice
Circ. Res., February 5, 1999; 84(2): 179 - 185.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Matsubara
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Circ. Res., December 14, 1998; 83(12): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Tsutsumi, H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, et al.
Angiotensin II Type 2 Receptor Is Upregulated in Human Heart With Interstitial Fibrosis, and Cardiac Fibroblasts Are the Major Cell Type for Its Expression
Circ. Res., November 16, 1998; 83(10): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al.
Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Murasawa, Y. Mori, Y. Nozawa, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Moriguchi, Y. Shibasaki, Y. Tanaka, T. Iwasaka, et al.
Role of Calcium-Sensitive Tyrosine Kinase Pyk2/CAKß/RAFTK in Angiotensin II–Induced Ras/ERK Signaling
Hypertension, October 1, 1998; 32(4): 668 - 675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Tamura, S. Umemura, N. Nyui, K. Hibi, T. Ishigami, M. Kihara, Y. Toya, and M. Ishii
Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R1 - R9.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z.-Q. Wang, A. F. Moore, R. Ozono, H. M. Siragy, and R. M. Carey
Immunolocalization of Subtype 2 Angiotensin II (AT2) Receptor Protein in Rat Heart
Hypertension, July 1, 1998; 32(1): 78 - 83.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Murasawa, Y. Mori, Y. Nozawa, N. Gotoh, M. Shibuya, H. Masaki, K. Maruyama, Y. Tsutsumi, Y. Moriguchi, Y. Shibazaki, et al.
Angiotensin II Type 1 Receptor–Induced Extracellular Signal–Regulated Protein Kinase Activation Is Mediated by Ca2+/Calmodulin-Dependent Transactivation of Epidermal Growth Factor Receptor
Circ. Res., June 29, 1998; 82(12): 1338 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Liu, A. Leri, B. Li, X. Wang, W. Cheng, J. Kajstura, and P. Anversa
Angiotensin II Stimulation In Vitro Induces Hypertrophy of Normal and Postinfarcted Ventricular Myocytes
Circ. Res., June 15, 1998; 82(11): 1145 - 1159.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Harada, I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, et al.
Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice
Circulation, May 19, 1998; 97(19): 1952 - 1959.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Heymes, J.-S. Silvestre, C. Llorens-Cortes, F. Marotte, B. Chevalier, B. I. Levy, B. Swynghedauw, and J.-L. Samuel
Cardiac Senescence Is Associated with Enhanced Expression of Angiotensin II Receptor Subtypes
Endocrinology, May 1, 1998; 139(5): 2579 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Harada, I. Komuro, Y. Zou, S. Kudoh, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, and Y. Yazaki
Acute Pressure Overload Could Induce Hypertrophic Responses in the Heart of Angiotensin II Type 1a Knockout Mice
Circ. Res., April 20, 1998; 82(7): 779 - 785.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Senzaki, Y. A. Gluzband, P. H. Pak, M. T. Crow, J. S. Janicki, and D. A. Kass
Synergistic Exacerbation of Diastolic Stiffness From Short-term Tachycardia–Induced Cardiodepression and Angiotensin II
Circ. Res., March 9, 1998; 82(4): 503 - 512.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Sumida, S. Umemura, K. Tamura, M. Kihara, S.-i. Kobayashi, T. Ishigami, M. Yabana, N. Nyui, H. Ochiai, A. Fukamizu, et al.
Increased Cardiac Angiotensin II Receptors in Angiotensinogen-Deficient Mice
Hypertension, January 1, 1998; 31(1): 45 - 49.
[Abstract] [Full Text]


Home page
CirculationHome page
N. Ohkubo, H. Matsubara, Y. Nozawa, Y. Mori, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Tsutumi, Y. Shibazaki, et al.
Angiotensin Type 2 Receptors Are Reexpressed by Cardiac Fibroblasts From Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism
Circulation, December 2, 1997; 96(11): 3954 - 3962.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
M. van Bilsen
Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system
Cardiovasc Res, December 1, 1997; 36(3): 310 - 322.
[Full Text] [PDF]


Home page
HypertensionHome page
N. Makino, M. Sugano, S. Otsuka, and T. Hata
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
Hypertension, October 1, 1997; 30(4): 796 - 802.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Tamura, Y. E. Chen, M. Lopez-Ilasaca, L. Daviet, N. Tamura, T. Ishigami, M. Akishita, I. Takasaki, Y. Tokita, R. E. Pratt, et al.
Molecular Mechanism of Fibronectin Gene Activation by Cyclic Stretch in Vascular Smooth Muscle Cells
J. Biol. Chem., October 27, 2000; 275(44): 34619 - 34627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Murasawa, H. Matsubara, Y. Mori, H. Masaki, Y. Tsutsumi, Y. Shibasaki, I. Kitabayashi, Y. Tanaka, S. Fujiyama, Y. Koyama, et al.
Angiotensin II Initiates Tyrosine Kinase Pyk2-dependent Signalings Leading to Activation of Rac1-mediated c-Jun NH2-terminal Kinase
J. Biol. Chem., August 25, 2000; 275(35): 26856 - 26863.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. G. N. Serneri, M. Boddi, I. Cecioni, S. Vanni, M. Coppo, M. L. Papa, B. Bandinelli, I. Bertolozzi, G. Polidori, T. Toscano, et al.
Cardiac Angiotensin II Formation in the Clinical Course of Heart Failure and Its Relationship With Left Ventricular Function
Circ. Res., May 11, 2001; 88(9): 961 - 968.
[Abstract] [Full Text] [PDF]